Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations

Axel S. Merseburger, Thomas Björk, James Whitehouse, Davide Meani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science